1. Access to effective antimicrobials: a worldwide challenge;Laxminarayan;Lancet,2016
2. Guidelines for the Prevention and Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in Health Care Facilities,2017
3. Evidence to improve the treatment of infections caused by carbapenem-resistant Gram-negative bacteria;Perez;Lancet Infect Dis,2018
4. European Centre for Disease Prevention and Control (ECDC). Carbapenem-resistant Acinetobacter baumannii in healthcare settings. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/8-Dec-2016-RRA-Acinetobacter%20baumannii-Europe.pdf. [Accessed 31 October 2017].
5. World Health Organization Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics http://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/. [Accessed 27 February 2017].